| [1] |
World Health Organization. Global tuberculosis report 2024. Geneva: World Health Organization, 2024.
|
| [2] |
中华医学会结核病学分会. 老年肺结核诊断与治疗专家共识(2023版). 中华结核和呼吸杂志, 2023, 46(11):1068-1084. doi:10.3969/j.issn.1007-3205.2024.11.002.
|
| [3] |
Chen X, Giles J, Yao Y, et al. The path to healthy ageing in China: a Peking University-Lancet Commission. Lancet, 2022, 400(10367):1967-2006. doi:10.1016/S0140-6736(22)01546-X.
pmid: 36423650
|
| [4] |
Hu WH, Liu YY, Yang CH, et al. Developing and validating a Chinese multimorbidity-weighted index for middle-aged and older community-dwelling individuals. Age Ageing, 2022, 51(2):afab274. doi:10.1093/ageing/afab274.
|
| [5] |
中华人民共和国国家卫生和计划生育委员会. WS 196—2017结核病分类. 结核与肺部疾病杂志, 2024, 5(4):379-380. doi:10.19983/j.issn.2096-8493.2024055.
|
| [6] |
中华人民共和国国家卫生和计划生育委员会. WS 288—2017肺结核诊断. 结核与肺部疾病杂志, 2024, 5(4):376-378. doi:10.19983/j.issn.2096-8493.20250069.
|
| [7] |
中国防痨协会. 耐药结核病化学治疗指南(2015). 中国防痨杂志, 2015, 37 (5): 421-469. doi:10.3969/j.issn.1000-6621.2015.05.001.
|
| [8] |
中国疾病预防控制中心结核病预防控制中心. 中国结核病防治工作技术指南(2021年). 北京: 人民卫生出版社, 2021:156-246.
|
| [9] |
Siddiqi K, Stubbs B, Lin Y, et al. TB multimorbidity:a global health challenge demanding urgent attention. Int J Tuberc Lung Dis, 2021, 25(2):87-90. doi:10.5588/ijtld.20.0751.
pmid: 33656417
|
| [10] |
卢水华. 关注结核病共患病已成为公共卫生的需要. 结核与肺部疾病杂志, 2022, 3(4):255-260. doi:10.19983/j.issn.2096-8493.20220107.
|
| [11] |
周芳静, 冯慧莹, 方兰君, 等. 2016—2020年广东省活动性肺结核患者发现延迟的变化趋势及影响因素分析. 中国防痨杂志, 2023, 45(1):85-95. doi:10.19982/J.issn.1000 6621.20220389.
|
| [12] |
吴守媛, 兰慧, 刘云兰, 等. 重症肺结核定义的概况性评价. 中华结核和呼吸杂志, 2023, 46(8):760-773. doi:10.3760/cma.j.cn112147-20230517-00247.
|
| [13] |
中华人民共和国卫生部疾病预防控制局, 中华人民共和国卫生部医政司, 中国疾病预防控制中心. 中国结核病防治规划实施工作指南(2008年版). 北京: 中国协和医科大学, 2009:48.
|
| [14] |
Michel JP, Leonardi M, Martin M, et al. WHO’s report for the decade of healthy ageing 2021— 30 sets the stage for globally comparable data on healthy ageing. Lancet Healthy Longev, 2021, 2(3):e121-e122. doi:10.1016/S2666-7568(21)00002-7.
|
| [15] |
Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis, 1970, 23(7): 455-468. doi:10.1016/0021-9681(70)90054-8.
pmid: 26309916
|
| [16] |
World Health Organization. The world health report 2008:primary health care now more than ever. Geneva: World Hearth Organization, 2008.
|
| [17] |
章轶立, 黄馨懿, 齐保玉, 等. 老年人共病研究的现实意义、内容方法与前景展望. 中国循证医学杂志, 2023, 23(7):862-868. doi:10.7507/1672-2531.202302103.
|
| [18] |
Wetterling T. Pathogenesis of multimorbidity-what is known?. Z Gerontol Geriatr, 2021, 54(6):590-596. doi:10.1007/s00391-020-01752-z.
|
| [19] |
Tran PB, Kazibwe J, Nikolaidis GF, et al. Costs of multimorbidity: a systematic review and meta-analyses. BMC Med, 2022, 20(1):234. doi:10.1186/s12916-022-02427-9.
pmid: 35850686
|
| [20] |
Lin WQ, Luo LY, Li YH, et al. Trends in prevalence of multimorbidity for chronic diseases in China: serial cross-sectional surveys from 2009 to 2018. J Nutr Health Aging, 2024, 28(8):100260. doi:10.1016/j.jnha.2024.100260.
|
| [21] |
Sinha A, Suman SS, Subedi N, et al. Epidemiology of multimorbidity in Nepal: A systematic review and meta-analysis. J Multimorb Comorb, 2024, 14:26335565241284022. doi:10.1177/26335565241284022.
|
| [22] |
刘帅帅, 张露文, 陆翘楚, 等. 中国中老年人多重慢性病现状调查与健康损失因素研究:基于CHARLS 2018数据. 实用医学杂志, 2021, 37(4):518-524. doi:10.3969/j.issn.1006-5725.2021.04.020.
|
| [23] |
Geng Y, Jie W, He Y, et al. Prevalence and Patterns of Multimorbidity Among Adults Aged 18 Years and Older: China, 2018. China CDC weekly, 2023, 5(2): 35-39. doi:10.46234/ccdcw2023.007.
pmid: 36776686
|
| [24] |
喻月慧, 毛雅宣. 典型共病模式下老年慢性病患者医疗负担影响因素分析. 中国卫生政策研究, 2024, 17(11):35-43. doi:10.3969/j.issn.1674-2982.2024.11.005.
|
| [25] |
闫伟, 路云, 张冉, 等. 基于CHARLS数据分析的我国老年人共病现状研究. 中华疾病控制杂志, 2019, 23(4): 426-430. doi:10.16462/j.cnki.zhjbkz.2019.04.012.
|
| [26] |
Nunes BP, Flores TR, Mielke GI, et al. Multimorbidity and mortality in older adults: a systematic review and meta-analysis. Arch Gerontol Geriatr, 2016, 67: 130-138. doi:10.1016/j.archger.2016.07.008.
|
| [27] |
Stubbs B, Siddiqi K, Elsey H, et al. Tuberculosis and non-communicable disease multimorbidity: An analysis of the World Health Survey in 48 low- and middle-income countries. Int J Environ Res Public Health, 2021, 18(5):2439. doi:10.3390/ijerph18052439.
|
| [28] |
Brijoux T, Woopen C, Zank S. Multimorbidity in old age and its impact on life results. Z Gerontol Geriatr, 2021, 54(Suppl 2):108-113. doi:10.1007/s00391-021-01920-9.
pmid: 34160675
|
| [29] |
Guo X, Liu P, Guo J, et al. An unsupervised cluster analysis of multimorbidity patterns in older adults in Shenzhen, China. Front Public Health, 2025, 13:1557721. doi:10.3389/fpubh.2025.1557721.
|
| [30] |
韩婷婷, 刘桂珍, 陈秋奇, 等. 世界卫生组织《应对结核病及其共病合作行动框架》解读. 中国防痨杂志, 2023, 45(1):25-30. doi:10.19982/j.issn.1000-6621.20220464.
|
| [31] |
Dong YH, Chang CH, Wu FL, et al. Use of inhaled corticosteroids in patients with COPD and the risk of TB and influenza:A systematic review and meta analysis of randomized controlled trials. Chest, 2014, 145(6):1286-1297. doi:10.1378/chest.13-2137.
|
| [32] |
Hu S, Yu Q, Liu F, et al. A novel inflammatory indicator for tuberculosis associated obstructive pulmonary disease(TOPD): the Systemic Inflammatory Response Index (SIRI). J Inflamm Res, 2024, 17:4219-4228. doi:10.2147/JIR.S468232.
|
| [33] |
Fan H, Wu F, Liu J, et al. Pulmonary tuberculosis as a risk factor for chronic obstructive pulmonary disease: a systematic review and meta-analysis. Ann Transl Med, 2021, 9(5):390. doi:10.21037/atm-20-4576.
pmid: 33842611
|
| [34] |
杨蕊, 李玲, 陈金瓯, 等. 2017—2021年云南省肺结核与糖尿病共病患者抗结核治疗效果及影响因素分析. 中国防痨杂志, 2024, 46(5):519-524. doi:10.19982/j.issn.1000-6621.20240006.
|
| [35] |
姚晶, 顾凯侃, 李智红, 等. 2014—2019年上海市静安市老年与非老年肺结核流行特征对比分析. 中国防痨杂志, 2020, 42(12):1323-1328. doi:10.3969/j.issn.1000-6621.2020.12.014.
|
| [36] |
杨超, 王晶, 杨朝辉, 等. 2016—2022年北京市通州区60岁及以上老年人群肺结核流行特征及治疗转归分析. 中国防痨杂志, 2021, 43(6):636-641. doi:10.19982/j.issn.1000-6621.20230416.
|
| [37] |
叶智腾, 任斐, 王华, 等. 老年耐多药/利福平耐药肺结核患者的治疗转归及影响因素研究——全国多中心、回顾性队列研究. 中国防痨杂志, 2024, 46(9):1023-1029. doi:10.19982/j.issn.1000-6621.20240215.
|
| [38] |
Rajagopalan S. Tuberculosis in Older Adults. Clin Geriatr Med, 2016, 32(3):479-491. doi:10.1016/j.cger.2016.02.006.
pmid: 27394018
|
| [39] |
Schaaf HS, Collins A, Bekker A, et al. Tuberculosis at extremes of age. Respirology, 2010, 15(5):747-763. doi:10.1111/j.1440-1843.2010.01784.x.
pmid: 20546192
|
| [40] |
World Health Organization. Treatment of tuberculosis: guidelines, 4th edition. Geneva:World Health Organization, 2020. doi:10.1177/17579139101300050803.
|
| [41] |
Li SJ, Li YF, Song WM, et al. Population aging and trends of pulmonary tuberculosis incidence in the elderly. BMC Infect Dis, 2021, 21(1):302. doi:10.1186/s12879-021-05994-z.
|
| [42] |
Louie JK, Keh C, Agraz-Lara R, et al. Adverse events associated with treatment for Pan-Susceptible tuberculosis in San Francisco. Clin Infect Dis, 2023, 76(6):1121-1124. doi:10.1093/cid/ciac867.
|
| [43] |
Boni FG, Hamdi I, Koundi LM, et al. Cytokine storm in tuberculosis and IL-6 involvement. Infect Genet Evol, 2022, 97:105166. doi:10.1016/j.meegid.2021.105166.
|
| [44] |
Kornfeld H, West K, Kane K, et al. High prevalence and heterogeneity of diabetes in patients with TB in South India: a report from the effects of diabetes on tuberculosis severity (EDOTS) study. Chest, 2016, 149(6):1501-1508. doi:10.1016/j.chest.2016.02.675.
pmid: 26973015
|
| [45] |
Ho J, Fox OJ, Marais BJ. Passive case finding for tuberculosis is not enough. Int J Mycobacteriol, 2016, 5(4):374-378. doi:10.1016/j.ijmyco.2016.09.023.
pmid: 27931676
|
| [46] |
Getnet F, Demissie M, Assefa N, et al. Delay in diagnosis of pulmonary tuberculosis in low-and middle-income settings:systematic review and meta-analysis. BMC Pulm Med, 2017, 17(1):202. doi:10.1186/s12890-017-0551-y.
|
| [47] |
An C, Chen H, Cheng Y, et al. Socioeconomic inequality in the multimorbidity trajectories of middle-aged and older adults in China: A prospective cohort study. Maturitas, 2025, 192:108160. doi:10.1016/j.maturitas.2024.108160.
|
| [48] |
李丽萍, 廖婧, 高鑫源, 等. 中国共病加权指数与老年人卫生服务利用的关联性研究. 中国全科医学, 2025, 28(1):65-70. doi:10.12114/j.issn.1007-9572.2023.0713.
|
| [49] |
李济宾, 张晋昕, 洪明晃. 临床研究方法学. 北京: 科学出版社, 2025.
|
| [50] |
Palmer K, Marengoni A, Forjaz MJ, et al. Multimorbidity care model: recommendations from the consensus meeting of the Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS). Health Policy, 2018, 122(1): 4-11. doi:10.1016/j.healthpol.2017.09.006.
pmid: 28967492
|